OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
July 08, 2017
Recro Gainsville expands its tableting capacity with the addition of a tablet press and film coater.
July 06, 2017
Lilly will provide up to $52 million in funding for research, making this Purdue’s largest strategic corporate collaboration
July 05, 2017
A Supreme Court decision and improvements in analytical processes may speed the biosimilar approval process.
SOBI003 is a chemically modified variant of a recombinant human sulfamidase product candidate, using Sobi’s proprietary glycan modification technology.
Samsung BioLogics signs $55.5 million agreement to manufacture tildrakizumab for Sun Pharma.
ADV7103 is being evaluated in a Phase III trial in Europe in children and adults with distal renal tubulopathy acidosis. Results from the study are expected in the coming months.
July 03, 2017
The Spanish CDMO has installed a new automatic capsule filling machine at its EU GMP-approved plant in Pamplona, Spain
July 02, 2017
Industry experts discuss the single-use revolution and changes to upstream and downstream processing equipment.
Oral solid-dosage and parenteral drug manufacturing equipment and systems have made great strides in safety and efficiency.
Anil Kane, executive director, Global Head of Technical & Scientific Affairs at Patheon, shared his perspective of changes to solid-dosage pharmaceutical manufacturing.